# A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-iii-randomized-placebo-controlled-study-of-belimumab-a-monoclonal/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Richard Furie,Michelle Petri,Omid Zamani,Ricard Cervera,Daniel J. Wallace,Dana Tegzová,Jorge Sánchez‐Guerrero,Andreas Schwarting,Joan T. Merrill,Winn Chatham,William Stohl,Ellen M. Ginzler,Douglas R. Hough,Z. John Zhong,William W. Freimuth,Ronald van Vollenhoven,BLISS-76 Study Group |
| Citations | 1,675 |
| DOI | 10.1002/art.30613 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | https://soar.suny.edu/bitstream/20.500.12648/8249/1/nihms805718.pdf |
| OpenAlex ID | https://openalex.org/W2136149088 |
| PMID | 22127708 |
| Type | article |
| Year | 2011 |

## Paper authors

- [Richard Furie](https://scholariq.org/researchers/richard-furie/)
- [Joan T. Merrill](https://scholariq.org/researchers/joan-t-merrill/)
- [Daniel J. Wallace](https://scholariq.org/researchers/daniel-j-wallace/)
- [Ronald van Vollenhoven](https://scholariq.org/researchers/ronald-van-vollenhoven/)
- [Michelle Petri](https://scholariq.org/researchers/michelle-petri/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.